BmGPAC, an antigen capture assay for detection of active babesia microti infection

Jose Thekkiniath, Sara Mootien, Lauren Lawres, Benjamin A. Perrin, Meital Gewirtz, Peter J. Krause, Scott Williams, Joseph Doggett, Michel Ledizet, Choukri Ben Mamoun

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Human babesiosis is an emerging zoonotic infectious disease caused by intraerythrocytic protozoan parasites of the genus Babesia. Most cases of human babesiosis are caused by Babesia microti and often manifest in individuals over the age of 50 years or in patients with a compromised immune system. Patients who develop symptomatic B. microti infections usually experience months of asymptomatic infection after the acute infection has resolved. About one-fifth of B. microtiinfected adults never develop symptoms. These asymptomatically infected individuals sometimes donate blood and thus can transmit B. microti through blood transfusion. Current assays for detection of active B. microti infections can be used to screen donor blood prior to transfusion, but they rely primarily on microscopy or PCR methods, which have sensitivity and technical limitations. Here we report the development of an antigen capture enzyme-linked immunosorbent assay (BmGPAC) based on a major secreted immunodominant antigen of B. microti (BmGPI12/BmSA1), and we provide evidence that this assay is superior for detection of active B. microti infections, compared to available microscopy methods and serological assays. The assay has been evaluated using supernatants of B. microti-infected erythrocytes cultured in vitro, sera from B. microti-infected laboratory mice, and sera from wild mice and human patients. Our data suggest that the BmGPAC assay is a reliable assay for detection of active B. microti infections and is superior to real-time PCR and antibody assays for diagnosis of acute B. microti infections, screening of the blood supply, and epidemiological surveys of humans and animal reservoir hosts.

Original languageEnglish (US)
Article numbere00067
JournalJournal of Clinical Microbiology
Volume56
Issue number10
DOIs
StatePublished - Oct 1 2018
Externally publishedYes

Fingerprint

Babesia microti
Antigens
Infection
Babesiosis
Microscopy
Emerging Communicable Diseases
Babesia
Immunodominant Epitopes
Asymptomatic Infections
Zoonoses
Blood Donors
Serum
Blood Transfusion
Real-Time Polymerase Chain Reaction
Immune System
Parasites

Keywords

  • Antigen
  • Babesia microti
  • Babesiosis
  • BmGPI12
  • Diagnosis
  • Transfusion

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Thekkiniath, J., Mootien, S., Lawres, L., Perrin, B. A., Gewirtz, M., Krause, P. J., ... Mamoun, C. B. (2018). BmGPAC, an antigen capture assay for detection of active babesia microti infection. Journal of Clinical Microbiology, 56(10), [e00067]. https://doi.org/10.1128/JCM.00067-18

BmGPAC, an antigen capture assay for detection of active babesia microti infection. / Thekkiniath, Jose; Mootien, Sara; Lawres, Lauren; Perrin, Benjamin A.; Gewirtz, Meital; Krause, Peter J.; Williams, Scott; Doggett, Joseph; Ledizet, Michel; Mamoun, Choukri Ben.

In: Journal of Clinical Microbiology, Vol. 56, No. 10, e00067, 01.10.2018.

Research output: Contribution to journalArticle

Thekkiniath, J, Mootien, S, Lawres, L, Perrin, BA, Gewirtz, M, Krause, PJ, Williams, S, Doggett, J, Ledizet, M & Mamoun, CB 2018, 'BmGPAC, an antigen capture assay for detection of active babesia microti infection', Journal of Clinical Microbiology, vol. 56, no. 10, e00067. https://doi.org/10.1128/JCM.00067-18
Thekkiniath J, Mootien S, Lawres L, Perrin BA, Gewirtz M, Krause PJ et al. BmGPAC, an antigen capture assay for detection of active babesia microti infection. Journal of Clinical Microbiology. 2018 Oct 1;56(10). e00067. https://doi.org/10.1128/JCM.00067-18
Thekkiniath, Jose ; Mootien, Sara ; Lawres, Lauren ; Perrin, Benjamin A. ; Gewirtz, Meital ; Krause, Peter J. ; Williams, Scott ; Doggett, Joseph ; Ledizet, Michel ; Mamoun, Choukri Ben. / BmGPAC, an antigen capture assay for detection of active babesia microti infection. In: Journal of Clinical Microbiology. 2018 ; Vol. 56, No. 10.
@article{ecde997498824e3d876d4c65efd7d775,
title = "BmGPAC, an antigen capture assay for detection of active babesia microti infection",
abstract = "Human babesiosis is an emerging zoonotic infectious disease caused by intraerythrocytic protozoan parasites of the genus Babesia. Most cases of human babesiosis are caused by Babesia microti and often manifest in individuals over the age of 50 years or in patients with a compromised immune system. Patients who develop symptomatic B. microti infections usually experience months of asymptomatic infection after the acute infection has resolved. About one-fifth of B. microtiinfected adults never develop symptoms. These asymptomatically infected individuals sometimes donate blood and thus can transmit B. microti through blood transfusion. Current assays for detection of active B. microti infections can be used to screen donor blood prior to transfusion, but they rely primarily on microscopy or PCR methods, which have sensitivity and technical limitations. Here we report the development of an antigen capture enzyme-linked immunosorbent assay (BmGPAC) based on a major secreted immunodominant antigen of B. microti (BmGPI12/BmSA1), and we provide evidence that this assay is superior for detection of active B. microti infections, compared to available microscopy methods and serological assays. The assay has been evaluated using supernatants of B. microti-infected erythrocytes cultured in vitro, sera from B. microti-infected laboratory mice, and sera from wild mice and human patients. Our data suggest that the BmGPAC assay is a reliable assay for detection of active B. microti infections and is superior to real-time PCR and antibody assays for diagnosis of acute B. microti infections, screening of the blood supply, and epidemiological surveys of humans and animal reservoir hosts.",
keywords = "Antigen, Babesia microti, Babesiosis, BmGPI12, Diagnosis, Transfusion",
author = "Jose Thekkiniath and Sara Mootien and Lauren Lawres and Perrin, {Benjamin A.} and Meital Gewirtz and Krause, {Peter J.} and Scott Williams and Joseph Doggett and Michel Ledizet and Mamoun, {Choukri Ben}",
year = "2018",
month = "10",
day = "1",
doi = "10.1128/JCM.00067-18",
language = "English (US)",
volume = "56",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - BmGPAC, an antigen capture assay for detection of active babesia microti infection

AU - Thekkiniath, Jose

AU - Mootien, Sara

AU - Lawres, Lauren

AU - Perrin, Benjamin A.

AU - Gewirtz, Meital

AU - Krause, Peter J.

AU - Williams, Scott

AU - Doggett, Joseph

AU - Ledizet, Michel

AU - Mamoun, Choukri Ben

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Human babesiosis is an emerging zoonotic infectious disease caused by intraerythrocytic protozoan parasites of the genus Babesia. Most cases of human babesiosis are caused by Babesia microti and often manifest in individuals over the age of 50 years or in patients with a compromised immune system. Patients who develop symptomatic B. microti infections usually experience months of asymptomatic infection after the acute infection has resolved. About one-fifth of B. microtiinfected adults never develop symptoms. These asymptomatically infected individuals sometimes donate blood and thus can transmit B. microti through blood transfusion. Current assays for detection of active B. microti infections can be used to screen donor blood prior to transfusion, but they rely primarily on microscopy or PCR methods, which have sensitivity and technical limitations. Here we report the development of an antigen capture enzyme-linked immunosorbent assay (BmGPAC) based on a major secreted immunodominant antigen of B. microti (BmGPI12/BmSA1), and we provide evidence that this assay is superior for detection of active B. microti infections, compared to available microscopy methods and serological assays. The assay has been evaluated using supernatants of B. microti-infected erythrocytes cultured in vitro, sera from B. microti-infected laboratory mice, and sera from wild mice and human patients. Our data suggest that the BmGPAC assay is a reliable assay for detection of active B. microti infections and is superior to real-time PCR and antibody assays for diagnosis of acute B. microti infections, screening of the blood supply, and epidemiological surveys of humans and animal reservoir hosts.

AB - Human babesiosis is an emerging zoonotic infectious disease caused by intraerythrocytic protozoan parasites of the genus Babesia. Most cases of human babesiosis are caused by Babesia microti and often manifest in individuals over the age of 50 years or in patients with a compromised immune system. Patients who develop symptomatic B. microti infections usually experience months of asymptomatic infection after the acute infection has resolved. About one-fifth of B. microtiinfected adults never develop symptoms. These asymptomatically infected individuals sometimes donate blood and thus can transmit B. microti through blood transfusion. Current assays for detection of active B. microti infections can be used to screen donor blood prior to transfusion, but they rely primarily on microscopy or PCR methods, which have sensitivity and technical limitations. Here we report the development of an antigen capture enzyme-linked immunosorbent assay (BmGPAC) based on a major secreted immunodominant antigen of B. microti (BmGPI12/BmSA1), and we provide evidence that this assay is superior for detection of active B. microti infections, compared to available microscopy methods and serological assays. The assay has been evaluated using supernatants of B. microti-infected erythrocytes cultured in vitro, sera from B. microti-infected laboratory mice, and sera from wild mice and human patients. Our data suggest that the BmGPAC assay is a reliable assay for detection of active B. microti infections and is superior to real-time PCR and antibody assays for diagnosis of acute B. microti infections, screening of the blood supply, and epidemiological surveys of humans and animal reservoir hosts.

KW - Antigen

KW - Babesia microti

KW - Babesiosis

KW - BmGPI12

KW - Diagnosis

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=85054168585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054168585&partnerID=8YFLogxK

U2 - 10.1128/JCM.00067-18

DO - 10.1128/JCM.00067-18

M3 - Article

VL - 56

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 10

M1 - e00067

ER -